8CCK
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8cck by Molmil](/molmil-images/mine/8cck) | |
8CCL
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8ccl by Molmil](/molmil-images/mine/8ccl) | |
8CCJ
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8ccj by Molmil](/molmil-images/mine/8ccj) | |
8CCM
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8ccm by Molmil](/molmil-images/mine/8ccm) | |
8CCI
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8cci by Molmil](/molmil-images/mine/8cci) | Crystal structure of Mycobacterium smegmatis thioredoxin reductase | Descriptor: | FLAVIN-ADENINE DINUCLEOTIDE, GLYCEROL, MAGNESIUM ION, ... | Authors: | Fuesser, F.T, Koch, O, Kuemmel, D. | Deposit date: | 2023-01-27 | Release date: | 2023-07-26 | Last modified: | 2023-09-13 | Method: | X-RAY DIFFRACTION (1.56 Å) | Cite: | Novel starting points for fragment-based drug design against mycobacterial thioredoxin reductase identified using crystallographic fragment screening. Acta Crystallogr D Struct Biol, 79, 2023
|
|